ezogabine has been researched along with Abdominal Epilepsy in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 24 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berry, NS; Crean, CS; Reeve, R; Tompson, DJ | 1 |
| Biton, V; Brodie, MJ; Derossett, SE; Gil-Nagel, A; Nohria, V | 1 |
| Biton, V; DeRossett, S; Nohria, V; Partiot, A; Porter, RJ; Rosenfeld, WE; Sachdeo, R; Tompson, D | 1 |
| Brandt, C; Daniluk, J; DeRossett, S; Edwards, S; Lerche, H; Lotay, N | 1 |
| Brodie, MJ | 1 |
| Elger, CE; Graf, W; Hamer, HM; Kasper, B; Kull, A; Kurth, C; Nass, RD; Rosenow, F; Steinhoff, BJ; Strzelczyk, A; Surges, R | 1 |
| Kwan, P; Lim, KS; Lotay, N; White, R | 1 |
| Brodie, MJ; Elger, C; Gil-Nagel, A; Hall, S; Lerche, H; Mansbach, H; Nohria, V; Shin, P | 1 |
| Owen, RT | 1 |
| Abou-Khalil, BW; French, JA; Hall, S; Leroy, RF; Mansbach, H; Nohria, V; Shin, P; Yacubian, EM | 1 |
| Grippon, S; Kirkpatrick, P; Stafstrom, CE | 1 |
| Brickel, N; DeRossett, S; Gandhi, P; Hammond, J; VanLandingham, K | 1 |
| Burdette, DE; DeRossett, SE; Gil-Nagel, A; Hall, ST; Porter, RJ; Shaikh, S; White, R | 1 |
| Rheims, S; Ryvlin, P | 1 |
| Hecht, B | 1 |
| Brodie, MJ; Castiglia, M; Cyr, T; Gil-Nagel, A; Hall, S; Leroy, R; Twomey, C; VanLandingham, K | 1 |
| Cooper, J; Duffy, S; Glanville, J; Hugel, P; Lane, PW; Martyn-St James, M; McCool, R | 1 |
| Splinter, MY | 1 |
| Welty, TE; Yamada, M | 1 |
| Craig, D; Fox, D; Paton, F; Rice, S; Woolacott, N | 1 |
| Crean, CS; Tompson, DJ | 1 |
| Forsgren, L; Kristian, B; Stefan, F; Wachtmeister, K | 1 |
| Plosker, GL; Scott, LJ | 1 |
| Alves, WM; Nohria, V; Partiot, A; Porter, RJ; Sachdeo, R | 1 |
| Ebner, A; Höhling, J; Köhling, R; Pannek, H; Rundfeldt, C; Speckmann, E; Straub, H; Tuxhorn, I; Wolf, P | 1 |
10 review(s) available for ezogabine and Abdominal Epilepsy
| Article | Year |
|---|---|
Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.
Topics: Acetamides; Adult; Aged; Animals; Anticonvulsants; Carbamates; Dibenzazepines; Drug Resistant Epilepsy; Epilepsies, Partial; Female; Humans; Lacosamide; Male; Middle Aged; Nitriles; Phenylenediamines; Pyridones | 2015 |
Ezogabine: a novel antiepileptic as adjunctive therapy for partial onset seizures.
Topics: Animals; Anticonvulsants; Carbamates; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Epilepsies, Partial; Humans; Phenylenediamines; Time Factors | 2010 |
The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels.
Topics: Animals; Anticonvulsants; Carbamates; Epilepsies, Partial; Humans; KCNQ Potassium Channels; Muscle, Smooth; Phenylenediamines; Urinary Retention | 2012 |
Retigabine for partial onset seizures.
Topics: Animals; Anticonvulsants; Carbamates; Disease Models, Animal; Epilepsies, Partial; Humans; Phenylenediamines; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
[Retigabine. A novel anticonvulsant drug for the adjunctive treatment of partial seizures].
Topics: Animals; Anticonvulsants; Carbamates; Clinical Trials, Phase III as Topic; Epilepsies, Partial; Humans; Phenylenediamines; Potassium Channel Blockers | 2012 |
The efficacy and safety of retigabine and other adjunctive treatments for refractory partial epilepsy: a systematic review and indirect comparison.
Topics: Anticonvulsants; Carbamates; Disorders of Excessive Somnolence; Epilepsies, Partial; Humans; Phenylenediamines; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
Ezogabine (retigabine) and its role in the treatment of partial-onset seizures: a review.
Topics: Animals; Anticonvulsants; Carbamates; Dose-Response Relationship, Drug; Drug Interactions; Epilepsies, Partial; Humans; Phenylenediamines; Potassium Channels, Voltage-Gated | 2012 |
Ezogabine: an evaluation of its efficacy and safety as adjunctive therapy for partial-onset seizures in adults.
Topics: Adult; Animals; Anticonvulsants; Carbamates; Drug Interactions; Epilepsies, Partial; Humans; Phenylenediamines; Treatment Outcome | 2012 |
Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization : a NICE single technology appraisal.
Topics: Adolescent; Adult; Anticonvulsants; Carbamates; Cost-Benefit Analysis; Decision Support Techniques; Drug Industry; Epilepsies, Partial; Humans; Models, Theoretical; Phenylenediamines; Randomized Controlled Trials as Topic; Seizures; Young Adult | 2013 |
Clinical pharmacokinetics of retigabine/ezogabine.
Topics: Age Factors; Aged; Anticonvulsants; Biological Availability; Carbamates; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Epilepsies, Partial; Half-Life; Humans; Liver Diseases; Phenylenediamines; Renal Insufficiency | 2013 |
10 trial(s) available for ezogabine and Abdominal Epilepsy
| Article | Year |
|---|---|
Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamates; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Epilepsies, Partial; Female; Gait Disorders, Neurologic; Humans; Male; Middle Aged; Phenylenediamines; Tablets; Treatment Outcome; Young Adult | 2013 |
Safety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamates; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Phenylenediamines; Treatment Outcome | 2013 |
A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.
Topics: Adolescent; Adult; Anticonvulsants; Carbamates; Drug Administration Schedule; Drug Dosage Calculations; Drug Interactions; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Patient Safety; Phenylenediamines; Research Design; Risk Assessment; Time Factors; Treatment Outcome; United States; Young Adult | 2014 |
Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
Topics: Aged; Anticonvulsants; Carbamates; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Kaplan-Meier Estimate; Lamotrigine; Levetiracetam; Male; Middle Aged; Oxcarbazepine; Phenylenediamines; Piracetam; Seizures; Treatment Outcome; Triazines; Valproic Acid | 2015 |
Efficacy and safety of retigabine/ezogabine as adjunctive therapy in adult Asian patients with drug-resistant partial-onset seizures: A randomized, placebo-controlled Phase III study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamates; Double-Blind Method; Drug Resistant Epilepsy; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Phenylenediamines; Seizures; Skin Pigmentation; Treatment Outcome; Young Adult | 2016 |
Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.
Topics: Adult; Anticonvulsants; Carbamates; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Phenylenediamines; Prospective Studies; Treatment Outcome | 2010 |
Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamates; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Phenylenediamines; Treatment Outcome | 2011 |
Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamates; Double-Blind Method; Endpoint Determination; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Phenylenediamines; Treatment Outcome; Vital Signs; Young Adult | 2012 |
Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies.
Topics: Adult; Anticonvulsants; Carbamates; Dizziness; Drug Resistance; Epilepsies, Partial; Fatigue; Female; Headache; Humans; Male; Middle Aged; Phenylenediamines; Sleep Stages; Time; Treatment Outcome; Young Adult | 2012 |
Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Australia; Carbamates; Dose-Response Relationship, Drug; Epilepsies, Partial; Europe; Female; Humans; Male; Middle Aged; Phenylenediamines; Risk Assessment; Risk Factors; Treatment Outcome; United States | 2007 |
7 other study(ies) available for ezogabine and Abdominal Epilepsy
| Article | Year |
|---|---|
Ezogabine (Potiga) toxicity.
Topics: Adult; Anticonvulsants; Carbamates; Drug Labeling; Epilepsies, Partial; Humans; Phenylenediamines; United States; United States Food and Drug Administration | 2013 |
Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamates; Child; Death, Sudden, Cardiac; Drug Resistant Epilepsy; Electrocardiography; Epilepsies, Partial; Female; Germany; Humans; Incidence; Male; Middle Aged; Phenylenediamines; Product Surveillance, Postmarketing; Retrospective Studies; Seizures; Tertiary Care Centers; Treatment Outcome; Young Adult | 2016 |
Ezogabine (retigabine).
Topics: Animals; Anticonvulsants; Carbamates; Epilepsies, Partial; Humans; Phenylenediamines; Randomized Controlled Trials as Topic | 2011 |
Ezogabine (Potiga) for epilepsy.
Topics: Administration, Oral; Adult; Anticonvulsants; Carbamates; Drug Interactions; Epilepsies, Partial; Humans; Phenylenediamines | 2012 |
Retigabine as add-on treatment of refractory epilepsy--a cost-utility study in a Swedish setting.
Topics: Acetamides; Adult; Anticonvulsants; Carbamates; Cost-Benefit Analysis; Drug Therapy, Combination; Epilepsies, Partial; Health Care Costs; Humans; Lacosamide; Phenylenediamines; Quality-Adjusted Life Years; Sensitivity and Specificity; Sweden | 2013 |
Retigabine: in partial seizures.
Topics: Animals; Anticonvulsants; Carbamates; Epilepsies, Partial; Humans; Phenylenediamines | 2006 |
Effects of retigabine on rhythmic synchronous activity of human neocortical slices.
Topics: Action Potentials; Adolescent; Adult; Anticonvulsants; Bicuculline; Carbamates; Child; Child, Preschool; Epilepsies, Partial; Female; GABA Antagonists; Humans; Magnesium; Male; Neocortex; Phenylenediamines | 2001 |